June 15, 2024
Complex Regional Pain Syndrome Market

Complex Regional Pain Syndrome Market Is Driven By Rising Prevalence Of Chronic Pain

Complex regional pain syndrome is a debilitating chronic pain condition that primarily involves the extremities. It is characterized by symptoms such as persistent severe burning pain, swelling, sweating, skin color and temperature changes. It often develops after an injury, surgery, stroke or heart attack and disproportionately impacts women. Effective treatment options for complex regional pain syndrome are limited. Currently, the first line of treatment focuses on pain relief with drugs like anticonvulsants, antidepressants, bisphosphonates, physical therapy and sympathetic blockade.

The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 103.07 Mn in 2023 and is expected to exhibit a CAGR of 7.2%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The growing geriatric population and rising incidence of chronic diseases and injuries are major factors driving the complex regional pain syndrome market growth. Elderly people are more susceptible to chronic pain conditions like CRPS due to degenerative changes in the bones and joints. According to United Nations estimates, the global population aged 60 years and above is expected to reach 2 billion by 2050 from 1 billion in 2020. Moreover, rising physical inactivity, obesity and unsafe work environments are contributing to increasing incidence of fractures, sprains, strains and surgeries which can potentially lead to complex regional pain syndrome. The global market is also being stimulated by ongoing research on new drugs and treatment methods to manage this debilitating chronic pain disorder more effectively.

Market key trends

There is an increased focus on use of multidisciplinary treatment approaches for complex regional pain syndrome. Combination therapies involving pharmacological and non-pharmacological interventions such as physical therapy, osteopathic manipulation, occupational therapy, psychotherapy and complementary methods like acupuncture are becoming preferred over conventional symptomatic treatment. Several studies have shown that multimodal rehabilitative treatments that gradually increase mobility and functions result in better long term outcomes compared to pain medications alone. Researchers are also investigating alternative treatment options like spinal cord stimulation, gene therapy, stem cell therapy and mirror therapy for CRPS, which hold promise to transform management of this chronic neuropathic pain condition in future.

Porter’s Analysis

Threat of new entrants: The complex regional pain syndrome market has moderate threat of new entrants due to high research and development and costs involved.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of alternative treatment options.

Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of substitute raw materials.

Threat of new substitutes: Threat of new substitutes is low as there are limited alternative treatment options for complex regional pain syndrome.

Competitive rivalry: The market has high competitive rivalry due to presence of many global and regional players.

Key Takeaways

The global Complex Regional Pain Syndrome Market Size is expected to witness high growth over the forecast period.

Regional analysis: North America is expected to retain its dominant position over the forecast period supported by rising geriatric population suffering from CRPS, favorable reimbursement policies, and presence of key players. Asia Pacific is anticipated to witness fastest growth owing to rising healthcare expenditure, increasing medical tourism, and growing awareness regarding CRPS.

Key players operating in the complex regional pain syndrome market are Intercos S.p.A., Kolmar Korea Co. Ltd., Scalpi Cosmética sa, Cosmax Inc., Mana Products Inc., KBL cosmetics Ltd., Urist Cosmetics Incorporated, Fareva Holding SA, Milliona Cosmetics Co., Ltd., Skinlys, Maesa SAS, Schwanhäußer Holding GmbH & Co. KG, Tricorbraun Inc., Herrco Cosmetics Limited, Architectural Beauty, Allure Labs Inc., Case Mason Filling, Inc., Pardaco Trading Pte Ltd, and KDC/ONE among others.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it